human blood coagulation factor vii lyophilized

Italy

Drugs containing this active substance

  • PROVERTINUM

    It is used to treat and prevent bleeding in patients of all ages who have coagulation disorders caused by factor VII deficiency. It is indicated for both congenital and acquired disorders, for example, due to liver disease or the use of anticoagulants.

    Form: solution for infusion, powder and solvent for preparation

    Active substance Dosage
    human blood coagulation factor vii lyophilized -

    ATC: B02BD05

    Manufacturer: BAXALTA INNOVATIONS GMBH